Cancer news

Latest news, press releases and blog posts from Cancer Research UK.

Cancer Genes

DNA analysis brings scientists step closer to ‘complete picture’ of breast cancer

An analysis of the complete genetic code of hundreds of breast tumours could lead to more personalised care for patients.

Everything you really need to know about DNA sequencing

We explore how we got to where we are today with DNA sequencing and the science behind it.

Test could spare breast cancer patients unnecessary chemotherapy

A gene test may improve the way doctors treating women with early-stage breast cancer identify those who can safely avoid post-surgery chemotherapy.

Blood analysis could offer a real-time ‘snapshot’ of melanoma treatment

We explore the latest research from our scientists in Manchester that's tracking how melanomas respond to treatment by analysing patient blood samples.

Blocking the escape routes: how an HIV drug exposes skin cancer’s weaknesses

A new study from our scientists has found that treating melanoma cells with an HIV drug could make them more sensitive to a 'targeted' cancer drug.

Cancer ‘master control switch’ could help tumours hide from immune system

Scientists have found a crucial link between a gene often found to be overactive in cancer cells, and tumours’ ability to hide from the immune system.

Piecing together the mosaic: how genetic research is revealing new connections

As part of an international collaboration, our researchers have uncovered a link between a rare genetic syndrome and childhood brain tumours.

There’s a real sense of optimism around new ways of tackling lung cancer

From immunotherapy to 'targeted' drugs, we report back from a recent conference on lung cancer.

CRISPR gene editing: new chapter in cancer research or blot in the ethical copybook?

We explore a new revolutionary gene editing technology called CRISPR that's taking labs by storm as scientists look to understand the genetics behind cancer.

Grand Challenge six: target cancer’s ‘super-controller’

The sixth of our Grand Challenge topics is posing the question: can we target the cancer ‘super-controller’ MYC?

Pages